In a move aimed at improving its competitive position in computer-aided detection and enhancing its oncology product portfolio, Siemens Medical Solutions has acquired CADVision Medical Technologies. The 10-year-old R&D company, based in Jerusalem,
In a move aimed at improving its competitive position in computer-aided detection and enhancing its oncology product portfolio, Siemens Medical Solutions has acquired CADVision Medical Technologies. The 10-year-old R&D company, based in Jerusalem, Israel, has developed algorithms that detect and classify breast lesions. Siemens may leverage the technology, which is now undergoing clinical validation, across several applications and multiple modalities.
CMS Issues New Reimbursement Code for PSMA PET Agent POSLUMA
September 26th 2023The transitional pass-through payment reimbursement code for the FDA-approved PSMA PET agent for prostate cancer detection will be effective as of October 1, according to the Centers for Medicare and Medicare Services (CMS).
2 Clarke Drive
Cranbury, NJ 08512